VLA2001

Small biotech says its Covid-19 vaccine spurs more antibodies than AstraZeneca’s. Will supply deals come now?
Endpoints
Mon, 10/18/21 - 11:08 am
vaccines
COVID-19
AstraZeneca
VLA2001
Valneva
Valneva's not too late in COVID-19 as analysts eye $1.1B in 2022 vaccine sales
Fierce Pharma
Thu, 06/3/21 - 11:00 am
Valneva
COVID-19
vaccines
VLA2001
Valneva joins the phase 3 Covid-19 vaccine club
EP Vantage
Thu, 04/22/21 - 10:47 am
Valneva
VLA2001
vaccines
COVID-19
clinical trials
Ocugen
Covaxin
Valneva Initiates Phase 1/2 Clinical Study of Inactivated, Adjuvanted COVID-19 Vaccine Candidate
Drugs.com
Sun, 12/20/20 - 11:04 pm
Valneva
vaccines
clinical trials
COVID-19
VLA2001